Zilver® PTX® Drug-Eluting Peripheral Stent
DeviceTreatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.
NCT Number: NCT02271529
The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Frankston Hospital, Frankston, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.
Time frame: Immediately following completion of the stent placement procedure
Cook Group Incorporated
Industry
Zilver Paclitaxel(PTX) Thumbwheel Delivery System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05107869
Cardiovascular Diseases, Endothelial Dysfunction
Wauwatosa, Wisconsin, United States
View Trial DetailsNCT03206762
Cardiovascular Diseases, Peripheral Vascular Disease
Davenport, Iowa, United States
View Trial DetailsNCT06112054
Cardiovascular Diseases, Peripheral Vascular Disease
Dendermonde, Belgium
View Trial DetailsNCT02685098
Amputation, Arterial Occlusive Disease
Indianapolis, Indiana, United States
View Trial Details